122 related articles for article (PubMed ID: 10328564)
1. Comparative study on pharmacokinetics and in vivo alpha1-adrenoceptor binding of [3H]tamsulosin and [3H]prazosin in rats.
Ohkura T; Yamada S; Deguchi Y; Kimura R
Biol Pharm Bull; 1999 Apr; 22(4):412-7. PubMed ID: 10328564
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo occupancy by tamsulosin of alpha1-adrenoceptors in rat tissues in relation to the plasma concentration.
Ohkura T; Yamada S; Deguchi Y; Kimura R; Matsushima H; Higuchi S; Inagaki O; Honda K; Takenaka T
Life Sci; 1998; 63(24):2147-55. PubMed ID: 9851306
[TBL] [Abstract][Full Text] [Related]
3. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
Yamada S; Ohkura T; Deguchi Y; Kimura R
J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
[TBL] [Abstract][Full Text] [Related]
4. Comparison of [3H]tamsulosin and [3H]prazosin binding to wild-type and constitutively active alpha1B-adrenoceptors.
Hein P; Goepel M; Cotecchia S; Michel MC
Life Sci; 2000 Jun; 67(5):503-8. PubMed ID: 10993115
[TBL] [Abstract][Full Text] [Related]
5. Differential alpha1-adrenoceptor labeling by [3H]prazosin and [3H]tamsulosin.
Michel MC; Goepel M
Eur J Pharmacol; 1998 Jan; 342(1):85-92. PubMed ID: 9544796
[TBL] [Abstract][Full Text] [Related]
6. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
Yamada S; Ohkura T; Kimura R; Kawabe K
Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
[TBL] [Abstract][Full Text] [Related]
7. Tamsulosin: assessment of affinity of 3H-prazosin bindings to two alpha1-adrenoceptor subtypes (alpha1H and alpha1L) in bovine prostate and rat heart and brain.
Maruyama K; Nakamura T; Yoshihara T; Fukutomi J; Sugiyama K; Hattorim K; Ohnuki T; Watanabe K; Nagatomo T
Gen Pharmacol; 1998 Oct; 31(4):597-600. PubMed ID: 9792222
[TBL] [Abstract][Full Text] [Related]
8. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
[TBL] [Abstract][Full Text] [Related]
9. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics.
Taguchi K; Schäfers RF; Michel MC
Br J Clin Pharmacol; 1998 Jan; 45(1):49-55. PubMed ID: 9489594
[TBL] [Abstract][Full Text] [Related]
10. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
Büscher R; Heeks C; Taguchi K; Michel MC
Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
[TBL] [Abstract][Full Text] [Related]
11. In vivo demonstration of alpha(1A)-adrenoceptor subtype selectivity of KMD-3213 in rat tissues.
Yamada S; Okura T; Kimura R
J Pharmacol Exp Ther; 2001 Jan; 296(1):160-7. PubMed ID: 11123376
[TBL] [Abstract][Full Text] [Related]
12. High-affinity specific [3H]tamsulosin binding to alpha 1-adrenoceptors in human prostates with benign prostatic hypertrophy.
Yamada S; Tanaka C; Ohkura T; Mori R; Kimura R; Inagaki O; Honda K; Kawabe K
Urol Res; 1994; 22(5):273-8. PubMed ID: 7533443
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.
Ohkura T; Yamada S; Tohma A; Kimura R; Aisaka K
Biol Pharm Bull; 1999 Jul; 22(7):687-90. PubMed ID: 10443463
[TBL] [Abstract][Full Text] [Related]
14. Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
Maruyama K; Fukutomi J; Chiba T; Yamaguchi M; Takeda M; Hattori K; Nagatomo T
Gen Pharmacol; 1996 Dec; 27(8):1377-81. PubMed ID: 9304410
[TBL] [Abstract][Full Text] [Related]
15. Effects of tamsulosin metabolites at alpha-1 adrenoceptor subtypes.
Taguchi K; Saitoh M; Sato S; Asano M; Michel MC
J Pharmacol Exp Ther; 1997 Jan; 280(1):1-5. PubMed ID: 8996174
[TBL] [Abstract][Full Text] [Related]
16. Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues.
Yamada S; Okura T; Kimura R; Deguchi Y; Suzuki Y; Kobayashi T; Aisaka K
Drug Metab Dispos; 2000 Dec; 28(12):1487-92. PubMed ID: 11095588
[TBL] [Abstract][Full Text] [Related]
17. Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.
Yamada S; Kato Y; Okura T; Kagawa Y; Kawabe K
Biol Pharm Bull; 2007 Jul; 30(7):1237-41. PubMed ID: 17603160
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.
Murata S; Taniguchi T; Muramatsu I
Br J Pharmacol; 1999 May; 127(1):19-26. PubMed ID: 10369451
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
20. In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonists.
Williams TJ; Blue DR; Daniels DV; Davis B; Elworthy T; Gever JR; Kava MS; Morgans D; Padilla F; Tassa S; Vimont RL; Chapple CR; Chess-Williams R; Eglen RM; Clarke DE; Ford AP
Br J Pharmacol; 1999 May; 127(1):252-8. PubMed ID: 10369480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
